Molecular mechanisms underlying K+ current downregulation in canine tachycardia-induced heart failure.
Heart failure (HF) is characterized by marked prolongation of action potential duration and reduction in cellular repolarization reserve. These changes are caused in large part by HF-induced K(+) current downregulation. Molecular mechanisms underlying these changes remain unclear. We determined whether downregulation of K(+) currents in a canine model of tachycardia-induced HF is caused by altered expression of underlying K(+) channel alpha- and beta-subunits encoding these currents. K(+) channel subunit expression was quantified in normal and failing dogs at the mRNA and protein levels in epicardial (Epi), midmyocardial (Mid), and endocardial (Endo) layers of left ventricle. Analysis of mRNA and protein levels of candidate genes encoding the transient outward K(+) current (I(to)) revealed marked reductions in canine cKv4.3 expression in HF in Epi (44% mRNA, 39% protein), Mid (52% mRNA, 34% protein), and Endo (49% mRNA, 73% protein) layers and a paradoxical enhancement (41% Epi, 97% Mid, 113% Endo) in cKv1.4 protein levels, without significant changes in Kv channel-interacting protein cKChIP2 expression. Expression of cKir2.1, the gene underlying inward rectifier K(+) current (I(K1)), was unaffected by HF at mRNA and protein levels despite significant reduction in I(K1), whereas canine ether-a-go-go-related gene (cERG), which encodes the rapidly activating component of the delayed rectifier current (I(K)), exhibited increased protein expression. HF was not accompanied by significant changes in cKvLQT1 or cMinK mRNA and protein levels. These data indicate that 1) downregulation of I(to) in HF is associated with decreased cKv4.3 and not cKv1.4 or cKChIP2, and 2) alterations in both the rapidly activating and slowly activating components of I(K) as well as I(K1) in nonischemic dilated cardiomyopathy are not caused by changes in either transcript or immunoreactive protein levels of relevant channel subunits, which suggests posttranslational modification of these currents by HF.
Akar
Fadi G
FG
Johns Hopkins Univ., School of Medicine, 720 Rutland Ave., Ross 844, Baltimore, MD 21205, USA.
Wu
Richard C
RC
Juang
George J
GJ
Tian
Yanli
Y
Burysek
Mirka
M
Disilvestre
Deborah
D
Xiong
Wei
W
Armoundas
Antonis A
AA
Tomaselli
Gordon F
GF
D000200:Action Potentials / Q000502:physiology; D000818:Animals; D004195:Disease Models, Animal; D004285:Dogs; D005260:Female; D005786:Gene Expression Regulation / Q000502:physiology; D006333:Heart Failure / Q000209:etiology / Q000503:physiopathology*; D008297:Male; D032342:Muscle Cells / Q000502:physiology*; D011188:Potassium / Q000502:physiology; D015221:Potassium Channels / Q000502:physiology*; D024642:Potassium Channels, Voltage-Gated / Q000235:genetics*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D051672:Shal Potassium Channels; D013610:Tachycardia / Q000503:physiopathology*
D015221:Potassium Channels; D024642:Potassium Channels, Voltage-Gated; D051672:Shal Potassium Channels; D011188:Potassium